Literature DB >> 36260550

Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic review.

Janey Sewell1, Ibidun Fakoya2, Fiona C Lampe1, Alison Howarth1, Andrew Phillips1, Fiona Burns1,3, Alison J Rodger1,3, Valentina Cambiano1.   

Abstract

INTRODUCTION: HIV transmission continues among gay and bisexual men who have sex with men (GBMSM), with those who are younger, or recent migrants, or of minority ethnicity or who are gender diverse remaining at increased risk. We aimed to identify and describe recent studies evaluating the effectiveness of HIV prevention interventions for GBMSM in high income countries.
METHODS: We searched ten electronic databases for randomized controlled trials (RCTs), conducted in high income settings, and published since 2013 to update a previous systematic review (Stromdahl et al, 2015). We predefined four outcome measures of interest: 1) HIV incidence 2) STI incidence 3) condomless anal intercourse (CLAI) (or measure of CLAI) and 4) number of sexual partners. We used the National Institute for Health and Care Excellence (UK) Quality Appraisal of Intervention Studies tool to assess the quality of papers included in the review. As the trials contained a range of effect measures (e.g. odds ratio, risk difference) comparing the arms in the RCTs, we converted them into standardized effect sizes (SES) with 95% confidence intervals (CI).
RESULTS: We identified 39 original papers reporting 37 studies. Five intervention types were identified: one-to-one counselling (15 papers), group interventions (7 papers), online interventions (9 papers), Contingency Management for substance use (2 papers) and Pre-exposure Prophylaxis (PrEP) (6 papers). The quality of the studies was mixed with over a third of studies rated as high quality and 11% rated as poor quality. There was some evidence that one-to-one counselling, group interventions (4-10 participants per group) and online (individual) interventions could be effective for reducing HIV transmission risk behaviours such as condomless anal intercourse. PrEP was the only intervention that was consistently effective at reducing HIV incidence.
CONCLUSIONS: Our systematic review of the recent evidence that we were able to analyse indicates that PrEP is the most effective intervention for reducing HIV acquisition among GBMSM. Targeted and culturally tailored behavioural interventions for sub-populations of GBMSM vulnerable to HIV infection and other STIs should also be considered, particularly for GBMSM who cannot access or decline to use PrEP.

Entities:  

Mesh:

Year:  2022        PMID: 36260550      PMCID: PMC9581368          DOI: 10.1371/journal.pone.0276209

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  57 in total

1.  Combination prevention: a deeper understanding of effective HIV prevention.

Authors:  Catherine A Hankins; Barbara O de Zalduondo
Journal:  AIDS       Date:  2010-10       Impact factor: 4.177

2.  Getting to Zero San Francisco: A Collective Impact Approach.

Authors:  Susan P Buchbinder; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12       Impact factor: 3.731

3.  The GATE frame: critical appraisal with pictures.

Authors:  Rod Jackson; Shanthi Ameratunga; Joanna Broad; Jennie Connor; Anne Lethaby; Gill Robb; Sue Wells; Paul Glasziou; Carl Heneghan
Journal:  Evid Based Med       Date:  2006-04

Review 4.  Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness.

Authors:  Theo Lorenc; Isaac Marrero-Guillamón; Peter Aggleton; Chris Cooper; Alexis Llewellyn; Angela Lehmann; Catriona Lindsay
Journal:  Sex Transm Infect       Date:  2011-03-25       Impact factor: 3.519

5.  An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men.

Authors:  Matthew J Mimiaga; David W Pantalone; Katie B Biello; Jackie M White Hughto; John Frank; Conall O'Cleirigh; Sari L Reisner; Arjee Restar; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Care       Date:  2019-03-19

6.  A Randomized Trial of an Online Risk Reduction Intervention for Young Black MSM.

Authors:  Lisa B Hightow-Weidman; Sara LeGrand; Kathryn E Muessig; Ryan A Simmons; Karina Soni; Seul Ki Choi; Helene Kirschke-Schwartz; Joseph R Egger
Journal:  AIDS Behav       Date:  2019-05

Review 7.  Systematic review of cognitive behavioural interventions for HIV risk reduction in substance-using men who have sex with men.

Authors:  G J Melendez-Torres; Chris Bonell
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

8.  The success of HIV combination prevention: The Dean Street model.

Authors:  Nicolò Girometti; Valerie Delpech; Sheena McCormack; Jameel Khawam; Sophie Nash; Dana Ogaz; Hamish Mohammed; Keerti Gedela; Diarmuid Nugent; Sheel Patel; Tara Suchak; Victoria Tittle; Alan McOwan; Gary Whitlock
Journal:  HIV Med       Date:  2021-07-29       Impact factor: 3.180

9.  Implementation and Operational Research: Computer-Assisted Intervention for Safer Sex in HIV-Positive Men Having Sex With Men: Findings of a European Randomized Multi-Center Trial.

Authors:  Christiana Nöstlinger; Tom Platteau; Johannes Bogner; Jozefien Buyze; Joanna Dec-Pietrowska; Sonia Dias; John Newbury-Helps; Agnes Kocsis; Matthias Mueller; Daniela Rojas; Danica Stanekova; Jacques van Lankveld; Robert Colebunders
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

10.  Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.

Authors:  Marie-Laure Chaix; Isabelle Charreau; Claire Pintado; Constance Delaugerre; Nadia Mahjoub; Laurent Cotte; Catherine Capitant; François Raffi; Eric Cua; Gilles Pialoux; Cécile Tremblay; Laurence Meyer; Jean-Michel Molina
Journal:  Open Forum Infect Dis       Date:  2018-11-08       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.